SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gets China’s National Medical Products Administration nod for Oseltamivir Phosphate

22 May 2026 Evaluate

Lupin has received approval from China’s National Medical Products Administration for its Abbreviated New Drug Application for Oseltamivir Phosphate, in partnership with Yabao Pharmaceuticals, a leader in China’s paediatric medicine market. This marks the company’s first product entry into China - a significant step in its global expansion.

Oseltamivir Phosphate for oral suspension, 6 mg/mL will be launched and commercialized to expand access, particularly for paediatric use. This expands the company’s global footprint and its commitment to delivering high-quality, affordable medicines to patients and children in need. Oseltamivir Phosphate for oral suspension, 6 mg (base)/mL is indicated for treatment of influenza A and B in patients 2 weeks of age and older; and for prevention of influenza A and B in individuals 1 year of age and older.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2329.95 2.45 (0.11%)
19-Jun-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1828.75
Dr. Reddys Lab 1265.90
Cipla 1358.10
Zydus Lifesciences 1077.20
Lupin 2329.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: